Fig. 6From: ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPcKaplan–Meier curves of overall survival between different groups in 94 breast cancer patients receiving NACT. Kaplan–Meier plots of overall survival of 94 patients stratified by a high/low ADAM10 expression of pre-NACT samples, b poor/good response to NACT and c different molecular breast cancer subtypes were demonstrated. Kaplan–Meier plots depicting the impact of high ADAM10 expression on overall survival of d ER + /HER2− subtype, e HER2-enriched subtype and f triple-negative subtype. Statistical analyses were performed using log-rank testsBack to article page